Discover how Medicare's new pilot program enhances access to CBD products for seniors, addressing chronic pain and altering cannabis regulations.

The CMS pilot program for CBD reimbursement highlights significant healthcare policy shifts and market implications. Learn how it impacts patient safety and insurance standards.

Explore the new Medicare program offering coverage for CBD expenses, enhancing treatment options for patients managing chronic pain and symptoms from cancer.

Explore the potential impacts of cannabis reclassification on banking and Medicare. Stay informed about new regulations and opportunities in the cannabis insurance sector.

CMS proposes Medicare coverage for federally and state-legal CBD products, highlighting evolving regulatory approaches amid clinical evidence and hemp legislation conflicts.

CMS proposes new Medicare rule to cover hemp-derived CBD products compliant with federal and state law, expanding treatment options for seniors and impacting healthcare costs.

CMS updates Medicare Advantage policy to allow insurance coverage for federally and state-legal CBD products, amid evolving hemp regulatory definitions and market challenges.

Texas is set to ban hemp-derived THC consumables like gummies and edibles, excluding non-intoxicating CBD and CBG products, amid market and regulatory concerns. The move impacts an $8 billion industry, reflecting ongoing challenges in hemp product oversight.